ALGERT GLOBAL LLC - PROQR THRAPEUTICS N V ownership

PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 65 filers reported holding PROQR THRAPEUTICS N V in Q1 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.

Quarter-by-quarter ownership
ALGERT GLOBAL LLC ownership history of PROQR THRAPEUTICS N V
ValueSharesWeighting
Q3 2022$8,0000.0%10,6650.0%0.00%
-100.0%
Q2 2022$8,000
-20.0%
10,665
-5.7%
0.00%0.0%
Q1 2022$10,000
-86.8%
11,310
+0.1%
0.00%
-96.2%
Q2 2021$76,000
+1.3%
11,3000.0%0.03%
+8.3%
Q1 2021$75,00011,3000.02%
Other shareholders
PROQR THRAPEUTICS N V shareholders Q1 2021
NameSharesValueWeighting ↓
M28 Capital Management LP 1,910,600$2,483,7802.85%
Privium Fund Management B.V. 5,344,446$6,947,7802.07%
DAFNA Capital Management LLC 940,582$1,222,7570.38%
Monaco Asset Management SAM 377,517$490,7720.15%
EcoR1 Capital, LLC 2,980,016$3,874,0210.13%
Ikarian Capital, LLC 472,625$614,4120.07%
FRANKLIN STREET ADVISORS INC /NC 150,000$1950.02%
ADAGE CAPITAL PARTNERS GP, L.L.C. 3,625,467$4,713,1070.01%
GSA CAPITAL PARTNERS LLP 74,084$960.01%
UBS OCONNOR LLC 189,328$246,1260.01%
View complete list of PROQR THRAPEUTICS N V shareholders